Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
JANX on Nasdaq
There are no Buy or Sell transactions made by Avalon Ventures XI, L.P. since 13 Mar 2025
Holdings reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2,789,272 |
$141,165,056 |
$50.61 |
16 Oct 2024 |
By Avalon BioVentures SPV I, LP |
|
|
| Common Stock |
2,115,373 |
$94,662,942 |
$44.75 |
18 Oct 2024 |
By Avalon BioVentures SPV I, L.P. |
|
|
| Common Stock |
2,071,799 |
$92,713,005 |
$44.75 |
18 Oct 2024 |
Direct |
|
|
| Common Stock |
401,321 |
$17,959,115 |
$44.75 |
18 Oct 2024 |
By Avalon BioVentures I, LP |
|
|
| Stock Option (right to buy) |
6,072 |
|
|
17 Oct 2024 |
Direct |
Common Stock |
|
Transactions reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.